NetworkNewsAudio Archive - Page 2 of 41

TuesdayFeb 27, 2024 8:00 am

NetworkNewsAudio – Diamond Lake Minerals Announces Strategic Investment in Avrio Worldwide, PBC

Related Press Release Diamond Lake Minerals, Inc. (OTC: DLMI) recently made a strategic investment in Avrio Worldwide, PBC to support deployment of Avrio’s registered digital financial market infrastructure (dFMI) for the tokenization of digital assets across DLMI’s network of companies. Avrio is the parent of several companies delivering licensed digital financial market infrastructure and services across public, private and digital markets. “DLMI’s strategic investment in Avrio offers outstanding opportunities and synergies across the DLMI network of companies for the tokenization of real-world-assets (RWA) on Avrio’s registered dFMI, as well as opportunities to invest in Avrio’s companies and commercial partners that…

TuesdayFeb 20, 2024 7:55 am

NetworkNewsAudio – Nextech3D.ai Launches Next Era of GPT AI 3D Solutions Led by Former Microsoft Executive

Related Press Release Nextech3D.AI (OTCQX:NEXCF) (CSE:NTAR) (FSE:1SS) recently announced that it is launching the next era of GPT AI 3D product solutions of proprietary Artificial Intelligence (AI) algorithms. The initiative will be led by former Microsoft Executive Hareesh Achi, who is Nextech3D.ai's current Head of Product Operations. The Company believes that the AI opportunity is in the early stages, and that the shift from 2D to 3D modeling for e-commerce is part of a major multi-decade transformation that is being led by AI. The Company is working on annual enterprise licensing deals for its suite of GPT AI solutions for…

FridayFeb 16, 2024 8:30 am

NetworkNewsAudio – Vision Marine Technologies Inc. (NASDAQ: VMAR) Leading Out in ‘Revolutionizing’ Recreational Boating Space

Related Editorial The raucous rumble of combustion engines is fading, systematically replaced by the high-performance hum of electric propulsion that’s transforming every aspect of transport. Electric cars have moved mainstream with both automakers and upstarts offering multiple mobility options. Now another market is being disrupted, as sleek electric boats glide across the water leaving nothing but a whisper of ripples in their wake. This surge in electrification isn't just about a clean and green conscience; it's about performance, convenience and a technological transition in mobility that may be as profound as the shift from the horse to the horseless carriage.…

WednesdayJan 17, 2024 3:00 am

NetworkNewsAudio – Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

Related Press Release Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, recently announced that it anticipates reporting record revenue and operating cashflow for the fourth quarter of 2023. The Company estimates that $2.8 million in cashflow from operating activities was generated for the quarter, compared to a negative cashflow of approximately $1.8 million for the same period a year earlier. With total expected revenue for last year estimated at $26.5 million, Alarum anticipates an increase of approximately 41% compared to the total revenue of 2022. Furthermore, it…

ThursdayJan 11, 2024 8:30 am

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looks to Supercharge Reach, Impact of GLP-1 Agonists with Proprietary Drug-Delivery Solution

Related Editorial Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential blockbuster therapeutic uses, according to recent research. Obviously, diabetes remains a primary indication, given the massive global need. However, the impact of this extraordinary molecule extends far beyond type 2 diabetes. The reach of GLP-1 drugs has widened in ways its inventors likely never imagined. Clinical trials are underway testing GLP-1 drugs to treat Alzheimer’s, Parkinson’s, and even drug addiction, plus there are strong indications of therapeutic efficacy in heart disease and…

FridayNov 17, 2023 7:55 am

NetworkNewsAudio – PaxMedica Inc. (NASDAQ: PXMD) Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data

Related Press Release PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, announced the completion of a type-B meeting with the FDA. During the live meeting, the company discussed the positive results of the recent data from its PAX-HAT-301 study of suramin in Stage One Human African Sleeping Sickness caused by Trypanosoma brucei rhodesiense, a rare and fatal parasitic disease if left untreated. To view the original press release, visit https://nnw.fm/CcN9z About PaxMedica Inc. PaxMedica is a forward-looking, clinical-stage biopharmaceutical firm specializing in cutting-edge anti-purinergic drug therapies (“APT”) aimed at addressing a range of challenging neurologic disorders. The company’s comprehensive portfolio encompasses a…

ThursdayNov 02, 2023 8:30 am

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Impact of Exclusive Drug-Delivery Solution on GLP-1 Drugs

Related Editorial The prestigious New England Journal of Medicine recently published results of a large study of 2,539 adults wherein weight loss of 49 to 52 pounds was a common outcome. With more than 37 million Americans suffering from diabetes, and with obesity at epidemic levels, it’s little wonder that millions of people are singing their praises of the new class of drugs responsible for these outrageously positive outcomes. GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with type 2 diabetes but are also helping treat obesity. Seems everyone is excited…

TuesdayOct 24, 2023 5:00 am

NetworkNewsAudio – Longeveron Announces Positive Top-Line Results for Lomecel-B(TM) in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease

Related Press Release Longeveron Inc. (Nasdaq: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, recently announced positive top-line results from its Phase 2a trial of its investigational product Lomecel-B™ for the treatment of mild Alzheimer’s disease. To view the original press release, visit https://nnw.fm/ckhHp About Longeveron Inc. Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B™ an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone…

FridayOct 13, 2023 8:30 am

NetworkNewsAudio – GEMXX Corp. (GEMZ) Differentiated from Others in Gold Sector by Vertical Integration Strategy

Related Editorial In volatile economic conditions, smart money seeks stability and moves to safe havens. Historically, one of the safest places and most stable spaces during economic uncertainty is gold, a highly liquid asset that preserves and even increases in value over time and carries no credit risk. The precious metal benefits from multiple levers of demand such as gold jewelry, tech/industrial use and a reserve asset as well as a strategic investment. History has shown that gold’s variable demand pressures enhance a portfolio by improving diversification, providing liquidity and delivering long-term returns. Reacting to uncertainties, many gold mining companies, including GEMXX Corp. (OTC: GEMZ)…

TuesdaySep 26, 2023 8:30 am

NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) Strategic Acquisitions Expand Company Footprint, Increase Revenue Stream, Grow Consumer Base

Related Editorial In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful companies usually measure this in terms of revenue streams, market share and product offerings. However, in the age of digital technology and globalization, a significant facet of growth potential is often found a company's core customer base and digital reputation. Lucy Scientific Discovery (NASDAQ: LSDI) (Profile) is astutely following this road map utilized by hugely successful corporations by uniquely leveraging user bases to rapidly amplify shareholder value. This well-established, albeit counterintuitive, M&A strategy has been utilized by…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsAudio